Filing Details
- Accession Number:
- 0001555280-22-000221
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-26 16:36:41
- Reporting Period:
- 2022-07-22
- Accepted Time:
- 2022-07-26 16:36:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1555280 | Zoetis Inc. | ZTS | Pharmaceutical Preparations (2834) | 460696167 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1567878 | Roxanne Lagano | C/O Zoetis Inc. 10 Sylvan Way Parsippany NJ 07054 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-22 | 1,163 | $73.24 | 24,850 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-07-22 | 1,004 | $87.51 | 25,854 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-07-22 | 2,167 | $180.26 | 23,687 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2022-07-22 | 1,163 | $0.00 | 1,163 | $0.00 |
| Common Stock | Stock Option | Disposition | 2022-07-22 | 1,004 | $0.00 | 1,004 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 38,573 | No | 4 | M | Direct | ||
| 37,569 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022.
- The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
- Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
- 1,163 options granted February 13, 2018 at an exercise price of $73.24 per option.
- Each option vests on the third anniversary of the date of grant.
- Each option expires on the tenth anniversary of the date of grant.
- 9,312 options granted February 13, 2018 at an exercise price of $73.24 per option; 9,040 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
- 1,004 options granted February 12, 2019 at an exercise price of $87.51 per option.
- 9,312 options granted February 13, 2018 at an exercise price of $73.24 per option; 8,036 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
Billionaire Hedge Funds
